Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.
作者信息
Blombery Piers, Thompson Ella R, Jones Kate, Arnau Gisela Mir, Lade Stephen, Markham John F, Li Jason, Deva Anand, Johnstone Ricky W, Khot Amit, Prince H Miles, Westerman David
机构信息
Peter MacCallum Cancer Centre, Melbourne, Australia
Peter MacCallum Cancer Centre, Melbourne, Australia University of Melbourne, Australia.
出版信息
Haematologica. 2016 Sep;101(9):e387-90. doi: 10.3324/haematol.2016.146118. Epub 2016 May 19.
Abstract
摘要
相似文献
1
Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.全外显子组测序揭示了乳房植入物相关间变性大细胞淋巴瘤中间变性大细胞淋巴瘤的JAK1和STAT3激活突变。
Haematologica. 2016 Sep;101(9):e387-90. doi: 10.3324/haematol.2016.146118. Epub 2016 May 19.
2
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.乳房植入物相关间变性大细胞淋巴瘤中的双JAK1和STAT3突变
Virchows Arch. 2018 Oct;473(4):505-511. doi: 10.1007/s00428-018-2352-y. Epub 2018 Apr 10.
3
Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.细胞因子受体信号对于 ALK-间变性大细胞淋巴瘤的存活是必需的，即使存在 JAK1/STAT3 突变也是如此。
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3975-3980. doi: 10.1073/pnas.1700682114. Epub 2017 Mar 29.
4
Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.下一代测序技术揭示了乳腺植入物相关间变性大细胞淋巴瘤中的新型 STAT3-JAK2 融合，以及 JAK-STAT 通路内的其他激活遗传改变。
Breast J. 2021 Apr;27(4):314-321. doi: 10.1111/tbj.14205. Epub 2021 Feb 18.
5
Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.乳房植入物相关间变性大细胞淋巴瘤的靶向二代测序揭示了JAK/STAT信号通路基因、TP53和DNMT3A中的突变。
Br J Haematol. 2018 Mar;180(5):741-744. doi: 10.1111/bjh.14431. Epub 2016 Nov 10.
6
Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.乳腺假体相关性间变大细胞淋巴瘤中 PDL1 表达和 PDL1（CD274）拷贝数改变的复发性。
Hum Pathol. 2019 Aug;90:60-69. doi: 10.1016/j.humpath.2019.05.007. Epub 2019 May 21.
7
18F-FDG-PET/CT in implant-associated anaplastic large cell lymphoma of the breast.18F-FDG-PET/CT在乳腺植入物相关间变性大细胞淋巴瘤中的应用
Br J Haematol. 2015 Apr;169(1):1. doi: 10.1111/bjh.13268. Epub 2014 Dec 18.
8
Anaplastic large cell lymphoma in a reconstructed breast using a silicone implant: a UK case report.硅酮假体乳房重建后发生间变大细胞淋巴瘤：英国病例报告。
J Plast Reconstr Aesthet Surg. 2014 Apr;67(4):561-3. doi: 10.1016/j.bjps.2013.09.015. Epub 2013 Sep 18.
9
Breast implant-associated Anaplastic large cell lymphoma (BIA-ALCL): Imaging findings.乳房植入物相关间变性大细胞淋巴瘤（BIA-ALCL）：影像学表现。
Breast J. 2019 Jul;25(4):728-730. doi: 10.1111/tbj.13312. Epub 2019 May 20.
10
Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.乳房植入物相关性间变大细胞淋巴瘤的分子驱动因素。
Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. doi: 10.1097/PRS.0000000000005570.
引用本文的文献
1
T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalities.接受嵌合抗原受体T细胞（CAR-T）治疗患者中的T细胞淋巴瘤：评估风险和因果关系
Blood. 2024 Dec 12;144(24):2473-2481. doi: 10.1182/blood.2024025828.
2
BIA-ALCL and BIA-SCC: Updates on Clinical Features and Genetic Mutations for Latest Recommendations.BIA-ALCL 和 BIA-SCC：最新建议中临床特征和基因突变的更新。
Medicina (Kaunas). 2024 May 10;60(5):793. doi: 10.3390/medicina60050793.
3
Flow Cytometry Analysis in Breast Implant-Associated Anaplastic Large Cell Lymphoma: Three Case Reports.流式细胞术分析在乳腺假体相关性间变大细胞淋巴瘤中的应用：三例报告。
Int J Mol Sci. 2024 Mar 20;25(6):3518. doi: 10.3390/ijms25063518.
4
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic.解答临床中“医生，CAR-T疗法会引发癌症吗？”这一问题。
Blood Adv. 2024 Feb 27;8(4):895-898. doi: 10.1182/bloodadvances.2023012336.
5
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in Poland: analysis of patient series and practical guidelines for breast surgeons.波兰的乳房植入物相关间变性大细胞淋巴瘤（BIA-ALCL）：患者系列分析及乳腺外科医生实用指南
Arch Med Sci. 2020 Nov 5;19(5):1243-1251. doi: 10.5114/aoms.2020.100637. eCollection 2023.
6
A genetic profiling guideline to support diagnosis and clinical management of lymphomas.用于支持淋巴瘤诊断和临床管理的基因谱分析指南。
Clin Transl Oncol. 2024 May;26(5):1043-1062. doi: 10.1007/s12094-023-03307-1. Epub 2023 Sep 6.
7
Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.基于腔隙的淋巴瘤：挑战与新观念。2022 年 EA4HP/SH 淋巴瘤研讨会报告。
Virchows Arch. 2023 Sep;483(3):299-316. doi: 10.1007/s00428-023-03599-2. Epub 2023 Aug 9.
8
How molecular advances may improve the diagnosis and management of PTCL patients.分子学进展如何改善外周T细胞淋巴瘤（PTCL）患者的诊断与管理。
Front Oncol. 2023 Jun 23;13:1202964. doi: 10.3389/fonc.2023.1202964. eCollection 2023.
9
Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.间变大细胞淋巴瘤中白介素-1 受体通路的分析与治疗靶点。
Blood. 2023 Oct 12;142(15):1297-1311. doi: 10.1182/blood.2022019166.
10
A rare case: synchronous ipsilateral breast implant-associated anaplastic large cell lymphoma and invasive ductal carcinoma.罕见病例：同步发生的同侧乳房植入物相关间变性大细胞淋巴瘤和浸润性导管癌。
J Surg Case Rep. 2023 Jun 9;2023(6):rjad338. doi: 10.1093/jscr/rjad338. eCollection 2023 Jun.
本文引用的文献
1
Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma.在乳房植入物相关间变性大细胞淋巴瘤中检测到细菌生物膜感染。
Plast Reconstr Surg. 2016 Jun;137(6):1659-1669. doi: 10.1097/PRS.0000000000002010.
2
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.完整手术切除对于乳房植入物相关间变性大细胞淋巴瘤患者的治疗至关重要。
J Clin Oncol. 2016 Jan 10;34(2):160-8. doi: 10.1200/JCO.2015.63.3412. Epub 2015 Nov 30.
3
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.乳房植入物相关间变性大细胞淋巴瘤：两种具有不同预后的独特临床病理变体。
Ann Oncol. 2016 Feb;27(2):306-14. doi: 10.1093/annonc/mdv575. Epub 2015 Nov 23.
4
Silicone implants and lymphoma: The role of inflammation.硅胶植入物与淋巴瘤：炎症的作用。
J Autoimmun. 2015 Dec;65:64-73. doi: 10.1016/j.jaut.2015.08.009. Epub 2015 Aug 29.
5
Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases.发生于隆胸女性的间变性大细胞淋巴瘤：173例分析。
Plast Reconstr Surg. 2015 Oct;136(4):553e-554e. doi: 10.1097/PRS.0000000000001601.
6
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.趋同突变和激酶融合导致间变性大细胞淋巴瘤中致癌性STAT3激活。
Cancer Cell. 2015 Apr 13;27(4):516-32. doi: 10.1016/j.ccell.2015.03.006.
7
Emergence of a STAT3 mutated NK clone in LGL leukemia.大颗粒淋巴细胞白血病中出现 STAT3 突变的自然杀伤细胞克隆。
Leuk Res Rep. 2014 Dec 16;4(1):4-7. doi: 10.1016/j.lrr.2014.12.001. eCollection 2015.
8
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.源自γδ-T细胞或NK细胞的淋巴瘤中STAT5B和STAT3的激活突变。
Nat Commun. 2015 Jan 14;6:6025. doi: 10.1038/ncomms7025.
9
Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma.乳房植入物中的慢性生物膜感染与T细胞淋巴细胞浸润增加有关：对乳房植入物相关淋巴瘤的影响。
Plast Reconstr Surg. 2015 Feb;135(2):319-329. doi: 10.1097/PRS.0000000000000886.
10
Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors.共同的 JAK1 和 JAK3 突变体能增加对 JAK 抑制剂的耐药性。
Blood. 2014 Dec 18;124(26):3924-31. doi: 10.1182/blood-2014-05-576652. Epub 2014 Oct 28.
Zotero 插件